[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591154":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":30,"responsibleParty":62,"collaborators":10,"id":64,"slug":10,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":69,"eligibilityCriteria":70,"healthyVolunteers":65,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":10,"studyType":77,"phases":10,"briefSummary":78,"conditions":79,"keywords":82,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"TScan Therapeutics, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"No study drug will be administered during this trial. Participants previously treated with TSC-100 or TSC-101 in a TScan study will be evaluated for long-term safety and efficacy.",[13],"Other: Observational",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":10},"OTHER","Long Term Follow-Up for participants treated with TSC-100 or TSC-101 TCR-T products",[9],[20],{"name":21,"affiliation":22,"role":23},"Michelle Matzko, MD","Medical Monitor","STUDY_DIRECTOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Madhavi Desai","CONTACT","(857) 399-9832","medicalaffairs@tscan.com",[31,49],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"City of Hope","RECRUITING","Duarte","California","91010","United States",{"type":39,"coordinates":40},"Point",[41,42],-117.97729,34.13945,{"lat":42,"lon":41},[45,47],{"name":46,"role":27,"phone":10,"phoneExt":10,"email":10},"Monzr M Al Malki, MD",{"name":46,"role":48,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"facility":50,"status":33,"city":51,"state":51,"zip":52,"country":37,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Mount Sinai","New York","10029-6696",{"type":39,"coordinates":54},[55,56],-74.00597,40.71427,{"lat":56,"lon":55},[59,61],{"name":60,"role":27,"phone":10,"phoneExt":10,"email":10},"Alla Keyzner, MD",{"name":60,"role":48,"phone":10,"phoneExt":10,"email":10},{"type":63,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100591154",false,"NCT06976736","A Long Term Follow-up Study of TScan TCR-T Products","A Long-term Follow-up Study to Assess Safety in Participants Who Received an Investigational T-Cell Receptor Engineered T-Cell (TCR-T) Product","LTFU","Inclusion Criteria:\n\n* Participants who received a TCR-T cellular therapy in a clinical study sponsored by TScan Therapeutics.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* None","ALL","18 Years","110 Years",{"count":75,"type":76},1000,"ESTIMATED","OBSERVATIONAL","The purpose of this Long-Term Follow-Up (LTFU) study is to monitor participants who have previously received TSC-100 or TSC-101 TCR-T therapies in the TSCAN-001 study. Participants will be monitored for 15 years from the date of TCR-T cell therapy administration to assess long-term safety and efficacy.",[80,71,81],"AML","MDS",[83,84,85,86,87,88,89],"TSCAN","Cell Therapies","TCR-T Cell Therapy","Long Term Follow-Up (LTFU)","TSC-101","TSC-100","TSCAN-001","2025-09-02",{"date":92,"type":93},"2025-09-10","ACTUAL",{"date":95,"type":76},"2025-09-09",{"date":97,"type":76},"2040-09",{"name":5,"class":6},2]